Plain-English translation of NCT06837831 on ClinicalTrials.gov โ ยท Source last updated ยท Translation generated ยท How we translate trials
This study doesn't follow the usual testing phases โ it may be an observational study or a different type of research.
Radiation therapy for rectal cancer often causes painful skin damage in the anal area, which can be severe enough to interrupt treatment. This trial is testing whether Mepilex Lite Dressings โ a special wound covering โ placed inside the anal canal, combined with indomethacin suppositories (a pain-relieving medication inserted rectally), can reduce this pain and help protect the damaged skin. The goal is to help patients complete their cancer treatment more comfortably and improve their quality of life.
Anal pain from radiation therapy is currently treated only with medication, but patients often experience pain relief that doesn't last long โ especially during bowel movements. This medication addresses pain after the fact, rather than protecting the sensitive skin from further damage. Researchers believe this new treatment approach might actively protect and heal the injured skin, offering better, longer-lasting relief.
You likely qualify ifโฆ
You likely don't qualify ifโฆ
If you join this trial, you will receive either the standard pain medication alone, or the same medication plus the special wound dressing inserted into the anal canal. You will insert the dressing (or medication suppository) before bed each night after emptying your bowels. Throughout your radiation therapy, the research team will monitor your pain levels and skin healing to see whether the dressing helps reduce pain and improve comfort during treatment.
AI-generated summary from trial data ยท Aug 11, 2026 ยท Not medical advice
China